Global Allopurinol Tablets Market Size, Share and Trends Analysis Report, By Type (100 mg and 300 mg), and By Application (Gout, Kidney Stones, and Others), Forecast (2022-2028)

The global allopurinol tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Allopurinol is used to treat gout and kidney stones. Additionally, it is used to prevent increased uric acid levels in patients receiving cancer chemotherapy. It can pile up and cause tiny, sharp crystals to form in and around your joints if create too much uric acid or kidneys do not filter it out enough. Gout is also more common in men over the age of 40, although it normally only affects women after menopause. As a result, the rising prevalence of gout is propelling the market forward over the forecast period. Based on type 100 mg Allopurinol tables has high demand in the market such as Allopurinol (100mg) is a xanthine oxidase inhibitor used to treat high uric acid levels caused by cancer medications.
The major factor driving the demand for allopurinol tablets is the new product launches in allopurinol to control, prevent gout and kidney stones diseases across the globe. For instance, in March 2019, Unichem Labs received USFDA approval for generic Zyloprim. Unichem Laboratories, a pharmaceutical business, has gained final approval from the US Food and Drug Administration to sell a generic version of Casper Pharma’s Zyloprim tablets that is a brand name of Allopurinol. It is used for the management of patients with signs and symptoms of primary or secondary gout. Additionally, in December 2020, Indoco Remedies Ltd. has been awarded tenders in Germany worth Rs 140 crore for the supply of Allopurinol tablets, which are used to treat gout and kidney stones. In Germany, the company secured big tenders around Rs 140 crore for Allopurinol tablets. This huge supply chain of Allopurinol tablets in Germany will help to cure gout and kidney stones-related disease.
Some major players in the market include Casper Pharma, Dr. Reddys Laboratories, Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., among others. The market players are serving significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, in order to stay competitive in the market. For instance, Zydus Cadila announced today that it has acquired final permission from the US Food and Drug Administration to market Allopurinol pills, which are intended to treat gout and other illnesses caused by excessive uric acid and serum in the body. The US Food and Drug Administration (USFDA) has given the company final approval to market Allopurinol tablets USP in strengths of 100 mg and 300 mg.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Top Major Key Players:
Casper Pharma, Dr. Reddys Laboratories, Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Allopurinol Tablets Market Report by Segment
By Type
100 mg
300 mg
By Application
Gout
Kidney Stones
Others